ABOUT IRDES

PUBLICATIONS

INTERNATIONAL

SURVEYS

CONFERENCES & WORKSHOPS

OUR SERVICES...

SYLVAIN PICHETTI

Senior research fellow
PhD in Economics


33 (0)1 53 93 43 55 pichetti@irdes.fr Assistant: Khadidja Ben Larbi

RESEARCH ACTIVITIES

Research interest

  • Statutory and complementary health insurance
  • Activity-based payment in hospitals: assessing the effects of the reform
  • Measurement of organization performance
  • Prescription drugs

Current interest

  • Impact of drug delisting on the prescription of mucolytics
  • Price determinants of me-too drugs
  • Diffusion of pharmaceutical innovation
  • Determinants of generic drug prescription (the example of statines)
  • Drug prescription efficiency

LATEST ENGLISH PUBLICATIONS

People with Disabilities Living at Home have Lower Access to Preventive Care than People without Disabilities Exploitation of the Health and Disability Survey, Household Section (2008)
Penneau A., Pichetti S., Sermet C. (Irdes)
Issues in Health Economics (Questions d'économie de la santé) n░ 208. 2015/04.

Institutionalisation Favours Access to Health Care for Disabled Persons Aged under 60 in France
Exploitation of the Health and Disability Households and Institutions survey (2008-2009)

Penneau A., Pichetti S., Sermet C. (Irdes)
Issues in Health Economics (Questions d'économie de la santé) n░ 207. 2015/03.

Entry time effects and follow-on drug competition.
Andrade L.F., Sermet C., Pichetti S., European Journal of Health Economics, on line le 12/12/2014. vol 17 n°1, 2016/01, 45-60.
On springer links site

Disabled Persons’ Access to Dental, Ophthalmological and Gynaecological Care in France
Exploitation of the Health and Disability Households survey (Enquête Handicap-Santé Ménages)

Lengagne P., Penneau A., Pichetti S., Sermet C. (Irdes)
Issues in Health Economics (Questions d'économie de la santé) n° 197. 2014/04

The Diffusion of New Anti-diabetic drugs: an International Comparison
Pichetti S. (Irdes), Sermet C. (Irdes), Van der Erf S. (Cnamts)
Issues in Health Economics (Questions d'économie de la santé) n° 187. 2013/05.

Multilevel Analysis of the Influence of Patients' and General Practitioners' Characteristics on Patented Versus Multiple-Sourced Statin Prescribing in France.
Pichetti S., Sermet C., Godman B., Campbell S.M., Gustafsson L.L., Applied Health Economics and Health Policy, on line, 2013/04, 1-14.
On Springer Link site

How to Explain Price Gaps between Me-too Drugs? A 2001-2009 Panel-data Analysis
Bergua L. (CHU de Rouen), Cartier T. (Université Paris Diderot, Sorbonne Paris Cité, Irdes), Célant N. (Irdes), Pichetti S. (Irdes), Sermet C. (Irdes), Sorasith C. (Irdes)
Issues in Health Economics (Questions d'économie de la santé) n° 178. 2012/07-08.

Analysis of the Impact of Drug Delisting in France between 2002 and 2011
Pichetti S., Sermet C.
Issues in Health Economics (Questions d'économie de la santé) n° 167. 2011/07-08

Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on presciption rates: A time-series analysis for France 1998-2010.
Pichetti S., Sorasith C., Sermet C., Health Policy, vol.102, issues 2-3, 2011/10, 159-169.

Encouraging direct access to OTC drugs in France
Pichetti S., Health Policy Monitor, 2009
Full text on the International network health policy & reform's site


More information on the French Site

Our newsletter
Subscribe
Contact
Legal information
Sitemap
Useful links
Access
News
Latest publications
RSS


September 15th, 2015